Complementary Methodologies for Analysis of NISTmAb Impurities

Applications | 2024 | Agilent TechnologiesInstrumentation
GPC/SEC, Capillary electrophoresis
Industries
Clinical Research
Manufacturer
Agilent Technologies
Downloadable PDF for viewing
 

Similar PDF

Analysis of NIST Antibody on the Agilent ProteoAnalyzer System
Fluorescence vs. UV Detection: Comparing Two CE-SDS Systems Using NISTmAb
Antibody-Drug Conjugate (ADC) Analysis with the Agilent ProteoAnalyzer System
Best Practices for Protein Analysis with the Agilent ProteoAnalyzer System